Vichy Neovadiol Magistral Day Cream: keep the Canadian details together

The product heading names Neovadiol Magistral Replenishing Redefining Day Cream and pairs Proxylane with Cassia extract for wrinkles and dry skin. Its post-menopause description focuses on visible firmness, plumpness and reduced-looking wrinkles. That establishes an appearance-care purpose; it does not demonstrate treatment of the wider symptoms that may prompt a menopause consultation. Canadian product description

The market matters because a similar collection name does not establish an identical preparation elsewhere. No net container quantity is stated in the material supporting this review, and we are not importing one from a UK or US listing. Our No7 Night Cream review is another separately identified product record to read. Canadian identity and purpose

Vichy calls the cream’s complex 30% omega-oil rich. The footnote says the complex consists of 14% oils together with vitamins B3 and E and glycerin. Reading the footnote changes the meaning of the number: the headline is not a declaration that 30% of the finished cream is oil, let alone one pure ingredient. Complex definition

The page separately highlights 1% Proxylane, Cassia extract, niacinamide and omega ingredients. Those manufacturer declarations give the formula discussion some specificity. They are not independent measurements or evidence that one percentage makes this cream better than another. The useful question is what each number refers to before comparing unlike mixtures or ingredient names. Key ingredient descriptions

The Canadian list names glycerin, dimethicone, shea butter, rice-bran oil and niacinamide, among other components. It also includes Cassia extract, fragrance and Capryloyl Salicylic Acid. This fuller declaration gives a reader concrete names to discuss, without relying entirely on the three ingredients emphasized in the marketing description. Canadian ingredient declaration

An ingredient list does not establish personal tolerability or answer a question about another product. For a separate nourishing-cream discussion, see our Emepelle Night Cream review. That navigation is not a claim that the creams have equivalent formulas or effects. Vichy’s own complete list remains the relevant reference for this Canadian preparation. Vichy declaration

The FAQ calls the preparation Magistral Firming Nourishing Day Balm, rather than the heading’s Replenishing Redefining Day Cream. It also says the balm has no exfoliating acids and uses that statement to reassure readers about combinations. The same page’s declaration names Capryloyl Salicylic Acid. We cannot make those statements agree by inferring an unseen formula revision. Day Balm FAQ and declaration

The broad combination reassurance is not adopted here, and the FAQ’s application suggestions are not repeated. An accurate answer would first clarify which preparation and declaration the answer describes. Our prescription questions guide addresses a different clinical category, but the habit of identifying the exact product is equally useful when a retail page changes names. Vichy naming and ingredient context

The main results report lower-face contour improvement of 25%, wrinkles reduced by 28% and dryness reduced by 50%, citing clinical scoring of 220 women after three months. Another panel gives 21% plumpness and 28% wrinkle improvement, with 219 women after three months. Those panels have different endpoints as well as different counts. Canadian result panels

The complete study explanation is not available to this review, so neither count is silently corrected or merged. FTC guidance stresses matching the outcome and population to the claim being made. That is the useful principle here, rather than treating every percentage on the page as one result or a predicted response for a new reader. FTC evidence relevance

Vichy describes a luscious, velvety texture and a fruity-floral scent. The FAQ’s Day Balm description emphasizes dry to very dry skin. These details help a reader understand the kind of product being offered. The sensitive-skin and hypoallergenic wording remains the manufacturer’s description, not proof that every reader will find its scent or richness comfortable. Texture and FAQ wording

AAD explains how moisture can make some fine lines less apparent. That context helps separate a nourishing cream’s appearance appeal from larger claims about menopause or a quantified study result. It does not establish Vichy’s measured percentages. Our facial versus menopause treatment guide similarly distinguishes the question of skin appearance from another treatment’s purpose. AAD moisture explanation

This cream offers a substantial ingredient declaration and a specific dry-skin appearance description. The unresolved issue is which label name, FAQ explanation and study group should accompany a quoted benefit. A useful response would keep the Canadian market and the exact preparation visible instead of substituting a more familiar Neovadiol name from another country. Vichy identity, FAQ and results

The medication-list guide concerns personal medicine records; it does not turn a day cream into hormone replacement. For Vichy, the product discussion can remain focused on its declared mixture, texture and qualified appearance evidence. The differences on the page leave a concrete clarification request, rather than a basis for personal combination or treatment advice. Vichy formula and claim context